Toxicity of pristine versus functionalized fullerenes: Mechanisms of cell damage and the role of oxidative stress

Archives of Toxicology

Volumn 86, Issue 12, 2012, Pages 1809-1827

  Trpkovic, Andreja ^a   Todorovic Markovic, Biljana ^a   Trajkovic, Vladimir ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cytotoxicity; Fullerenes; Genotoxicity; In vitro; In vivo; Oxidative stress

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CARBON; CARBON 60; DOXORUBICIN; ENVIRONMENTAL CHEMICAL; FULLERENE DERIVATIVE; FULLEROL; FUNCTIONAL GROUP; POLYMER; REACTIVE OXYGEN METABOLITE; SOLVENT; SURFACTANT; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BIOMEDICINE; BLOOD TOXICITY; CARDIOTOXICITY; CELL DAMAGE; CELL STRESS; CHEMICAL MODIFICATION; CHEMICAL PROCEDURES; CYTOTOXICITY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG MEGADOSE; DRUG METABOLISM; EYE TOXICITY; GENOTOXICITY; HEALTH HAZARD; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER TOXICITY; LOW DRUG DOSE; LUNG TOXICITY; MAMMAL CELL; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PHOTOTOXICITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SKIN TOXICITY; SOLUBILITY; SOLUBILIZATION; SOLVENT EXTRACTION; STRUCTURE ACTIVITY RELATION; SUSPENSION; TISSUE INJURY;

ANIMALS; CARDIOVASCULAR DISEASES; CELL SURVIVAL; EYE DISEASES; FULLERENES; FURANS; HUMANS; KIDNEY DISEASES; MUTAGENS; NERVOUS SYSTEM DISEASES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SKIN DISEASES;

MAMMALIA;

EID: 84871246370     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-012-0859-6     Document Type: Review

References (162)

1. Aoshima H, Saitoh Y, Ito S, Yamana S, Miwa N (2009) Safety evaluation of highly purified fullerenes (HPFs): based on screening of eye and skin damage. J Toxicol Sci 34:555-562.
2. Aoshima H, Yamana S, Nakamura S, Mashino T (2010) Biological safety of water-soluble fullerenes evaluated using tests for genotoxicity, phototoxicity, and pro-oxidant activity. J Toxicol Sci 35:401-409.
3. Arbogast JW, Darmanyan AP, Foote CS, Diederich FN, Whetten RL, Rubin Y, Alvarez MM, Samir J, Anz SJ (1991) Photophysical properties of C60. J Phys Chem 95:11-12.
4. Aschberger K, Johnston HJ, Stone V, Aitken RJ, Tran CL, Hankin SM, Peters SA, Christensen FM (2010) Review of fullerene toxicity and exposure-appraisal of a human health risk assessment, based on open literature. Regul Toxicol Pharmacol 58:455-473.
5. Babynin EV, Nuretdinov IA, Cubskaya VP, Barabanshchikov BI (2002) Study of mutagenetic activity of fullerene and some of its derivatives using his ? reversions of Salmonella typhimurium as an example. Russian J Genet 38:453-457.
6. Badireddy AR, Hotze EM, Chellam S, Alvarez P, Wiesner MR (2007) Inactivation of bacteriophages via photosensitizationof fullerol nanoparticles. Environ Sci Technol 41:6627-6632.
7. Baker GL, Gupta A, Clark ML, Valenzuela BR, Staska LM, Harbo SJ, Pierce JT, Dill JA (2008) Inhalation toxicity and lung toxicokinetics of C60 fullerene nanoparticles and microparticles. Toxicol Sci 101:122-131.
8. Bakry R, Vallant RM, Najam-ul-Haq M, Rainer M, Szabo Z, Huck CW, Bonn GK (2007) Medicinal applications of fullerenes. Int J Nanomedicine 2:639-649.
9. n; R = H, Et; n = 1-6. Phys Chem Chem Phys 3:4679-4683.
10. Blazer-Yost BL, Banga A, Amos A, Chernoff E, Lai X, Li C, Mitra S, Witzmann FA (2011) Effect of carbon nanoparticles on renal epithelial cell structure, barrier function, and protein expression. Nanotoxicology 5:354-371.
11. Bosi S, Da Ros T, Spalluto G, Prato M (2003) Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem 38:913-923.
12. Bosi S, Feruglio L, Da Ros T, Spalluto G, Gregoretti B, Terdoslavich M, Decorti G, Passamonti S, Moro S, (2004) Hemolytic effects of water-soluble fullerene derivatives. J Med Chem 47:6711-6715.
13. Bottasso O, Docena G, Stanford JL, Grange JM (2009) Chronic inflammation as a manifestation of defects in immunoregulatory networks: implications for novel therapies based on microbial products. Inflammopharmacology 17:193-203.
14. Briviba K, Klotz LO, Sies H (1997) Toxic and signaling effects of photochemically or chemically generated singlet oxygen in biological systems. Biol Chem 378:1259-1265.
15. Brunet L, Lyon DY, Hotze EM, Alvarez PJ, Wiesner MR (2009) Comparative photoactivity and antibacterial properties of C60 fullerenes and titanium dioxide nanoparticles. Environ Sci Technol 43:4355-4360.
16. Bullard Dillard R, Creek KE, Scrivens WA, Tour JM (1996) Tissue sites of uptake of 14C-labeled C60. Bioorg Chem 24:376-385.
17. Buseck PR, Tsipursky SJ, Hettich R (1992) Fullerenes from the geologic environment. Science 257:215-217.
18. Chen HH, Yu C, Ueng TH, Chen S, Chen BJ, Huang KJ, Chiang LY (1998) Acute and subacute toxicity study of water-soluble polyalkylsulfonated C60 in rats. Toxicol Pathol 26:143-151.
19. Chen F, Eriksson P, Hansson GK, Herzfeld I, Klein M, Hansson LO, Valen G (2005) Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque. Int J Mol Med 15:57-65.
20. Chien CT, Lee PH, Chen CF, Ma MC, Lai MK, Hsu SM (2001) De novo demonstration and co-localization of free-radical production and apoptosis formation in rat kidney subjected to ischemia/reperfusion. J Am Soc Nephrol 12:973-982.
21. Chirico F, Fumelli C, Marconi A, Tinari A, Straface E, Malorni W, Pellicciari R, Pincelli C (2007) Carboxyfullerenes localize within mitochondria and prevent the UVB-induced intrinsic apoptotic pathway. Exp Dermatol 16:429-436.
22. Da Ros T, Prato M (1999) Medicinal chemistry with fullerenes and fullerene derivatives. Chem Comm 8:663-669.
23. Davies MJ (2003) Singlet oxygen-mediated damage to proteins and its consequences. Biochem Biophys Res Commun 305:761-770.
24. Dhawan A, Taurozzi JS, Pandey AK, Shan W, Miller SM, Hashsham SA, Tarabara VV (2006) Stable colloidal dispersions of C60 fullerenes in water: evidence for genotoxicity. Environ Sci Technol 40:7394-7401.
25. Diederich F, Ettl R, Rubin Y, Whetten RL, Beck R, Alvarez M, Anz S, Sensharma D, Wudl F, Khemani KC, Koch A (1991) The higher fullerenes: isolation and characterization of C76, C84, C90, C94, and C70O, an oxide of D5 h-C70. Science 252:548-551.
26. Dugan LL, Gabrielsen JK, Yu SP, Lin TS, Choi DW (1996) Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol Dis 3:129-135.
27. Dugan LL, Lovett EG, Quick KL, Lotharius J, Lin TT, O'Malley KL (2001) Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat Disord 7:243-246.
28. Duncan LK, Jinschek JR, Vikesland PJ (2007) C60 colloid formation in aqueous systems: effects of preparation method on size, structure, and surface charge. Environ Sci Technol 42:173-178.
29. Ehrich M, Van Tassell R, Li Y, Zhou Z, Kepley CL (2011) Fullerene antioxidants decrease organophosphate-induced acetylcholinesterase inhibition in vitro. Toxicol In Vitro 25:301-307.
30. Ema M, Tanaka J, Kobayashi N, Naya M, Endoh S, Maru J, Hosoi M, Nagai M, Nakajima M, Hayashi M, Nakanishi J (2012) Genotoxicity evaluation of fullerene C60 nanoparticles in a comet assay using lung cells of intratracheally instilled rats. Regul Toxicol Pharmacol 62:419-424.
31. Foley S, Crowley C, Smaihi M, Bonfils C, Erlanger BF, Seta P, Larroque C (2002) Cellular localisation of a water-soluble fullerene derivative. Biochem Biophys Res Commun 294:116- 119.
32. Folkmann JK, Risom L, Jacobsen NR, Wallin H, Loft S, Møller P (2009) Oxidatively damaged DNA in rats exposed by oral gavage to C60 fullerenes and single-walled carbon nanotubes. Environ Health Perspect 117:703-708.
33. Fortner JD, Lyon DY, Sayes CM, Boyd AM, Falkner JC, Hotze EM, Alemany LB, Tao YJ, Guo W, Ausman KD, Colvin VL, Hughes JB (2005) C60 in water: nanocrystal formation and microbial response. Environ Sci Technol 39:4307-4316.
34. Fujita K, Morimoto Y, Ogami A, Myojyo T, Tanaka I, Shimada M, Wang WN, Endoh S, Uchida K, Nakazato T, Yamamoto K, Fukui H, Horie M, Yoshida Y, Iwahashi H, Nakanishi J (2009) Gene expression profiles in rat lung after inhalation exposure to C60 fullerene particles. Toxicology 258:47-55.
35. Gelderman MP, Simakova O, Clogston JD, Patri AK, Siddiqui SF, Vostal AC, Simak J (2008) Adverse effects of fullerenes on endothelial cells: fullerenol C60(OH)24 induced tissue factor and ICAM-I membrane expression and apoptosis in vitro. Int J Nanomedicine 3:59-68.
36. Gharbi N, Pressac M, Hadchouel M, Szwarc H, Wilson SR, Moussa F (2005) [60] Fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett 5:2578-2585.
37. Greim H, Norppa H (2010) Genotoxicity testing of nanomaterials- conclusions. Nanotoxicology 4:421-424.
38. Guldi DM, Prato M (2000) Excited-state properties of C60 fullerene derivatives. Acc Chem Res 33:695-703.
39. Guo T, Diener MD, Chai Y, Alford MJ, Haufler RE, McClure SM, Ohno T, Weaver JH, Scuseria GE, Smalley RE (1992) Uranium stabilization of C28: a tetravalent fullerene. Science 257:1661- 1664.
40. Hamano T, Okuda K, Mashino T, Hirobe M, Arakane K, Ryu A, Mashiko S, Nagano T (1997) Singlet oxygen production from fullerene derivatives: effect of sequential functionalization of the fullerene core. Chem Commun 1:21-22.
41. Han B, Karim MN (2008) Cytotoxicity of aggregated fullerene C60 particles on CHO and MDCK cells. Scanning 30:213-220.
42. Harhaji L, Isakovic A, Raicevic N, Markovic Z, Todorovic-Markovic B, Nikolic N, Vranjes-Djuric S, Markovic I, Trajkovic V (2007) Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene. Eur J Pharmacol 568:89-98.
43. Harhaji L, Isakovic A, Vucicevic L, Janjetovic K, Misirkic M, Markovic Z, Todorovic-Markovic B, Nikolic N, Vranjes-Djuric S, Nikolic Z, Trajkovic V (2008) Modulation of tumor necrosis factor-mediated cell death by fullerenes. Pharm Res 25:1365- 1376.
44. Henry TB, Menn FM, Fleming JT, Wilgus J, Compton RN, Sayler GS (2007) Attributing effects of aqueous C60 nano-aggregates to tetrahydrofuran decomposition products in larval zebrafish by assessment of gene expression. Environ Health Perspect 115:1059-1065.
45. Henry TB, Petersen EJ, Compton RN (2011) Aqueous fullerene aggregates (nC60) generate minimal reactive oxygen species and are of low toxicity in fish: a revision of previous reports. Curr Opin Biotechnol 22:533-537.
46. Hotze EM, Labille J, Alvarez P, Wiesner MR (2008) Mechanisms of photochemistry and reactive oxygen production by fullerene suspensions in water. Environ Sci Technol 42:4175-4180.
47. Huczko A, Lange H, Calko E (1999) Fullerenes: experimental evidence for a null risk of skin irritation and allergy. Fullerene Sci Technol 7:935-939.
48. Injac R, Boskovic M, Perse M, Koprivec-Furlan E, Cerar A, Djordjevic A, Strukelj B (2008) Acute doxorubicin nephrotoxicity in rats with malignant neoplasm can be successfully treated with fullerenol C60(OH)24 via suppression of oxidative stress. Pharmacol Rep 60:742-749.
49. Injac R, Perse M, Cerne M, Potocnik N, Radic N, Govedarica B, Djordjevic A, Cerar A, Strukelj B (2009) Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer. Biomaterials 30:1184-1196.
50. Isakovic A, Markovic Z, Nikolic N, Todorovic-Markovic B, Vranjes- Djuric S, Harhaji L, Raicevic N, Romcevic N, Vasiljevic- Radovic D, Dramicanin M, Trajkovic V (2006a) Inactivation of nanocrystalline C60 cytotoxicity by c-irradiation. Biomaterials 27:5049-5058.
51. Isakovic A, Markovic Z, Todorovic-Markovic B, Nikolic N, Vranjes- Djuric S, Mirkovic M, Dramicanin M, Harhaji L, Raicevic N, Nikolic Z, Trajkovic V (2006b) Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene. Toxicol Sci 91:173-183.
52. Ito S, Itoga K, Yamato M, Akamatsu H, Okano T (2010) The coapplication effects of fullerene and ascorbic acid on UV-B irradiated mouse skin. Toxicology 267:27-38.
53. Jacobsen NR, Pojana G, White P, Møller P, Cohn CA, Korsholm KS, Vogel U, Marcomini A, Loft S, Wallin H (2008) Genotoxicity, cytotoxicity, and reactive oxygen species induced by singlewalled carbon nanotubes and C60 fullerenes in the FE1-MutaTM Mouse lung epithelial cells. Environ Mol Mutagen 49:476-487.
54. Jacobsen NR, Møller P, Jensen KA, Vogel U, Ladefoged O, Loft S, Wallin H (2009) Lung inflammation and genotoxicity following pulmonary exposure to nanoparticles in ApoE-/- mice. Part Fibre Toxicol 6:2.
55. x in mice. J Nanoparticle Res 8:53-63.
56. Johnson-Lyles DN, Peifley K, Lockett S, Neun BW, Hansen M, Clogston J, Stern ST, McNeil SE (2010) Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunction. Toxicol Appl Pharmacol 248:249-258.
57. Johnston HJ, Hutchison GR, Christensen FM, Aschberger K, Stone V (2010) The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity. Toxicol Sci 114:162-182.
58. Kamat JP, Devasagayam TP, Priyadarsini KI, Mohan H, Mittal JP (1998) Oxidative damage induced by the fullerene C60 on photosensitization in rat liver microsomes. Chem Biol Interact 114:145-159.
59. Kamat JP, Devasagayam TP, Priyadarsini KI, Mohan H (2000) Reactive oxygen species mediated membrane damage induced by fullerene derivatives and its possible biological implications. Toxicology 155:55-61.
60. Käsermann F, Kempf C (1997) Photodynamic inactivation of enveloped viruses by buckminsterfullerene. Antiviral Res 34:65-70.
61. Kato S, Aoshima H, Saitoh Y, Miwa N (2009a) Biological safety of lipofullerene composed of squalane and fullerene-C60 upon mutagenesis, photocytotoxicity, and permeability into the human skin tissue. Basic Clin Pharmacol Toxicol 104:483-487.
62. Kato S, Aoshima H, Saitoh Y, Miwa N (2009b) Highly hydroxylated or c-cyclodextrin-bicapped water-soluble derivative of fullerene: the antioxidant ability assessed by electron spin resonance method and beta-carotene bleaching assay. Bioorg Med Chem Lett 19:5293-5296.
63. Kato S, Aoshima H, Saitoh Y, Miwa N (2010) Fullerene-C60/liposome complex: defensive effects against UVA-induced damages in skin structure, nucleus and collagen type I/IV fibrils, and the permeability into human skin tissue. J Photochem Photobiol B 98:99-105.
64. Kolosnjaj J, Szwarc H, Moussa F (2007) Toxicity studies of fullerenes and derivatives. Adv Exp Med Biol 620:168-180.
65. Kovochich M, Espinasse B, Auffan M, Hotze EM, Wessel L, Xia T, Nel AE, Wiesner MRR (2009) Comparative toxicity of C60 aggregates toward mammalian cells: role of tetrahydrofuran (THF) decomposition. Environ Sci Technol 43:6378-6384.
66. Krätschmer W, Lamb LD, Fostiropoulos K, Huffman DR (1990) Solid C60: a new form of carbon. Nature 347:354-358.
67. Kroto HW, Heath JR, O'Brien SC, Curl RF, Smalley RE (1985) C60: buckminsterfullerene. Nature 318:162-163.
68. Krusic PJ, Wasserman E, Keizer PN, Morton JR, Preston KF (1991) Radical reactions of C60. Science 254:1183-1185.
69. Leavens TL, Xia XR, Lee HA, Monteiro-Riviere NA, Brooks JD, Riviere JE (2010) Evaluation of perfused porcine skin as a model system to quantitate tissue distribution of fullerene nanoparticles. Toxicol Lett 197:1-6.
70. Lee YT, Chiang LY, Chen WJ, Hsu HC (2000) Water-soluble hexasulfobutyl[ 60]fullerene inhibit low-density lipoprotein oxidation in aqueous and lipophilic phases. Proc Soc Exp Biol Med 224:69-75.
71. Lens M (2011) Recent progresses in application of fullerenes in cosmetics. Recent Pat Biotechnol 5:67-73.
72. Li W, Chen C, Ye C, Wei T, Zhao Y, Lao F, Chen Z, Meng H, Gao Y, Yuan H, Xing G, Zhao F, Chai Z, Zhang X, Yang F, Han D, Tang X, Zhang Y (2008) The translocation of fullerenic nanoparticles into lysosome via the pathway of clathrin-mediated endocytosis. Nanotechnology 19:145102.
73. Lin JC, Wu CH (1999) Surface characterization and platelet adhesion studies on polyurethane surface immobilized with C60. Biomaterials 20:1613-1620.
74. Liu J, Ohta S, Sonoda A, Yamada M, Yamamoto M, Nitta N, Murata K, Tabata Y (2007) Preparation of PEG-conjugated fullerene containing Gd3 ions for photodynamic therapy. J Controlled Release 117:104-110.
75. Lu LH, Lee YT, Chen HW, Chiang LY, Huang HC (1998) The possible mechanisms of the antiproliferative effect of fullerenol, polyhydroxylated C60, on vascular smooth muscle cells. Br J Pharmacol 123:1097-1102.
76. Marano F, Hussain S, Rodrigues-Lima F, Baeza-Squiban A, Boland S (2011) Nanoparticles: molecular targets and cell signalling. Arch Toxicol 85:733-741.
77. Markovic Z, Trajkovic V (2008) Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60). Biomaterials 29:3561-3573.
78. Markovic Z, Todorovic-Markovic B, Kleut D, Nikolic N, Vranjes- Djuric S, Misirkic M, Vucicevic L, Janjetovic K, Isakovic A, Harhaji L, Babic-Stojic B, Dramicanin M, Trajkovic V (2007) The mechanism of cell-damaging reactive oxygen generation by colloidal fullerenes. Biomaterials 28:5437-5448.
79. Matsuda S, Matsui S, Shimizu Y, Matsuda T (2011) Genotoxicity of colloidal fullerene C60. Environ Sci Technol 45:4133-4138.
80. Metanawin T, Tang T, Chen R, Vernon D, Wang X (2011) Cytotoxicity and photocytotoxicity of structure-defined water-soluble C60/micelle supramolecular nanoparticles. Nanotechnology 22:235604.
81. Milic VD, Stankov K, Injac R, Djordjevic A, Srdjenovic B, Govedarica B, Radic N, Simic VD, Strukelj B (2009) Activity of antioxidative enzymes in erythrocytes after a single dose administration of doxorubicin in rats pretreated with fullerenol C60(OH)24. Toxicol Mech Methods 19:24-28.
82. Misirkic MS, Todorovic-Markovic BM, Vucicevic LM, Janjetovic KD, Jokanovic VR, Dramicanin MD, Markovic ZM, Trajkovic VS (2009) The protection of cells from nitric oxide-mediated apoptotic death by mechanochemically synthesized fullerene (C60) nanoparticles. Biomaterials 30:2319-2328.
83. Mori T, Takada H, Ito S, Matsubayashi K, Miwa N, Sawaguchi T (2006) Preclinical studies on safety of fullerene upon acute oral administration and evaluation for no mutagenesis. Toxicology 225:48-54.
84. Morimoto Y, Hirohashi M, Ogami A, Oyabu T, Myojo T, Nishi K, Kadoya C, Todoroki M, Yamamoto M, Murakami M, Shimada M, Wang WN, Yamamoto K, Fujita K, Endoh S, Uchida K, Shinohara N, Nakanishi J, Tanaka I (2010a) Inflammogenic effect of well-characterized fullerenes in inhalation and intratracheal instillation studies. Part Fibre Toxicol 7:4.
85. Morimoto Y, Kobayashi N, Shinohara N, Myojo T, Tanaka I, Nakanishi J (2010b) Hazard assessments of manufactured nanomaterials. J Occup Health 52:325-334.
86. Mrdanović J, Solajić S, Bogdanović V, Stankov K, Bogdanović G, Djordjevic A (2009) Effects of fullerenol C60(OH)24 on the frequency of micronuclei and chromosome aberrations in CHOK1 cells. Mutat Res 680:25-30.
87. Mroz P, Tegos GP, Gali H, Wharton T, Sarna T, Hamblin MR (2007) Photodynamic therapy with fullerenes. Photochem Photobiol Sci 6:1139-1149.
88. Nakagawa Y, Suzuki T, Ishii H, Nakae D, Ogata A (2011) Cytotoxic effects of hydroxylated fullerenes on isolated rat hepatocytes via mitochondrial dysfunction. Arch Toxicol 85:1429-1440.
89. Naota M, Shimada A, Morita T, Inoue K, Takano H (2009) Translocation pathway of the intratracheally instilled C60 fullerene from the lung into the blood circulation in the mouse: possible association of diffusion and caveolae-mediated pinocytosis. Toxicol Pathol 37:456-462.
90. Nielsen GD, Roursgaard M, Jensen KA, Poulsen SS, Larsen ST (2008) In vivo biology and toxicology of fullerenes and their derivatives. Basic Clin Pharmacol Toxicol 103:197-208.
91. Nikolić N, Vranjes-Ethurić S, Janković D, Ethokić D, Mirković M, Bibić N, Trajković V (2009) Preparation and biodistribution of radiolabeled fullerene C60 nanocrystals. Nanotechnology 20:385102.
92. Nitta N, Seko A, Sonoda A, Ohta S, Tanaka T, Takahashi M, Murata K, Takemura S, Sakamoto T, Tabata Y (2008) Is the use of fullerene in photodynamic therapy effective for atherosclerosis? Cardiovasc Intervent Radiol 31:359-366.
93. Niwa Y, Iwai N (2006) Genotoxicity in cell lines induced by chronic exposure to water-soluble fullerenes using micronucleus test. Environ Health Prev Med 11:292-297.
94. Niwa Y, Iwai N (2007) Nanomaterials induce oxidized low-density lipoprotein cellular uptake in macrophages and platelet aggregation. Circ J 71:437-444.
95. Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-839.
96. Ogami A, Yamamoto K, Morimoto Y, Fujita K, Hirohashi M, Oyabu T, Myojo T, Nishi K, Kadoya C, Todoroki M, Yamamoto M, Murakami M, Shimada M, Wang WN, Shinohara N, Endoh S, Uchida K, Nakanishi J, Tanaka I (2011) Pathological features of rat lung following inhalation and intratracheal instillation of C60 fullerene. Inhal Toxicol 23:407-416.
97. Park EJ, Kim H, Kim Y, Yi J, Choi K, Park K (2010) Carbon fullerenes (C60s) can induce inflammatory responses in the lung of mice. Toxicol Appl Pharmacol 244:226-233.
98. Partha R, Conyers JL (2009) Biomedical applications of functionalized fullerene-based nanomaterials. Int J Nanomedicine 4:261-275.
99. Pickering KD, Wiesner MR (2005) Fullerol-sensitized production of reactive oxygen species in aqueous solution. Environ Sci Technol 39:1359-1365.
100. Piskoti C, Yarger J, Zettl A (1998) C36, a new carbon solid. Nature 393:771-774.
101. Pizzarello S, Huang Y, Becker L, Poreda RJ, Nieman RA, Cooper G, Williams M (2001) The organic content of the Tagish Lake meteorite. Science 293:2236-2239.
102. Porter AE, Muller K, Skepper J, Midgley P, Welland M (2006) Uptake of C60 by human monocyte macrophages, its localization and implications for toxicity: studied by high resolution electron microscopy and electron tomography. Acta Biomater 2:409-419.
103. Prat F, Stackow R, Bernstein R, Qian W, Rubin Y, Foote CS (1999) Triplet-state properties and singlet oxygen generation in a homologous series of functionalized fullerene derivatives. J Phys Chem A 103:7230-7235.
104. Radomski A, Jurasz P, Alonso-Escolano D, Drews M, Morandi M, Malinski T, Radomski MW (2005) Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 146:882- 893.
105. Rajagopalan P, Wudl F, Schinazi RF, Boudinot FD (1996) Pharmacokinetics of a water-soluble fullerene in rats. Antimicrob Agents Chemother 40:2262-2265.
106. Rancan F, Rosan S, Boehm F, Cantrell A, Brellreich M, Schoenberger H, Hirsch A, Moussa F (2002) Cytotoxicity and photocytotoxicity of a dendritic C60 mono-adduct and a malonic acid C60 trisadduct on Jurkat cells. J Photochem Photobiol, B 67:157-162.
107. Ray PD, Huang BW (2012) Tsuji Y (2012) Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24:981-990.
108. Roberts JE, Wielgus AR, Boyes WK, Andley U, Chignell C (2008) Phototoxicity and cytotoxicity of fullerol in human lens epithelial cells. Toxicol Appl Pharmacol 228:49-58.
109. Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340:115-126.
110. 60 fullerene (fullerenol) attenuates neutrophilic lung inflammation in mice. Basic Clin Pharmacol Toxicol 103:386-388.
111. Rouse JG, Yang J, Barron AR, Monteiro-Riviere NA (2006) Fullerene-based amino acid nanoparticle interactions with human epidermal keratinocytes. Toxicol In Vitro 20:1313-1320.
112. Rouse JG, Yang J, Ryman-Rasmussen JP, Barron AR, Monteiro- Riviere NA (2007) Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. Nano Lett 7:155-160.
113. Saathoff JG, Inman AO, Xia XR, Riviere JE, Monteiro-Riviere NA (2011) In vitro toxicity assessment of three hydroxylated fullerenes in human skin cells. Toxicol In Vitro 25:2105-2112.
114. Saitoh Y, Miyanishi A, Mizuno H, Kato S, Aoshima H, Kokubo K, Miwa N (2011) Super-highly hydroxylated fullerene derivative protects human keratinocytes from UV-induced cell injuries together with the decreases in intracellular ROS generation and DNA damages. J Photochem Photobiol B 102:69-76.
115. Satoh M, Takayanagi I (2006) Pharmacological studies on fullerene (C60), a novel carbon allotrope, and its derivatives. Pharmacol Sci 100:513-518.
116. Sayes CM, Fortner JD, Guo W, Lyon D, Boyd AM, Ausman KD, Tao YJ, Sitharama B, Wilson LJ, Hughes JB, West JL, Colvin VL (2004) The differential cytotoxicity of water-soluble fullerenes. Nano Lett 4:1881-1887.
117. Sayes CM, Gobin AM, Ausman KD, Mendez J, West JL, Colvin VL (2005) Nano-C60 cytotoxicity is due to lipid peroxidation. Biomaterials 26:7587-7595.
118. Sayes CM, Marchione AA, Reed KL, Warheit DB (2007) Comparative pulmonary toxicity assessments of C60 water suspensions in rats: few differences in fullerene toxicity in vivo in contrast to in vitro profiles. Nano Lett 7:2399-2406.
119. Schins RPF, Knaapen AM (2007) Genotoxicity of poorly soluble particles. Inhal Toxicol 19(Suppl 1):189-198.
120. Scrivens WA, Tour JM (1994) Synthesis of 14C-labeled C60, its suspension in water, and its uptake by human keratinocytes. J Am Chem Soc 116:4517-4518.
121. Sera N, Tokiwa H, Miyata N (1996) Mutagenicity of the fullerene C60-generated singlet oxygen dependent formation of lipid peroxides. Carcinogenesis 17:2163-2169.
122. Shinohara N, Matsumoto K, Endoh S, Maru J, Nakanishi J (2009) In vitro and in vivo genotoxicity tests on fullerene C60 nanoparticles. Toxicol Lett 191:289-296.
123. 60 exposure. Toxicol Sci 118:564-573.
124. Simeonova PP, Erdely A (2009) Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers. Inhal Toxicol 21(Suppl 1):68-73.
125. Spohn P, Hirsch C, Hasler F, Bruinink A, Krug HF, Wick P (2009) C60 fullerene: a powerful antioxidant or a damaging agent? The importance of an in-depth material characterization prior to toxicity assays. Environ Pollut 157:1134-1139.
126. Su Y, Xu JY, Shen P, Li J, Wang L, Li Q, Li W, Xu GT, Fan C, Huang Q (2010) Cellular uptake and cytotoxic evaluation of fullerenol in different cell lines. Toxicology 269:155-159.
127. Tabata Y, Murakami Y, Ikada Y (1997) Photodynamic effect of polyethylene glycol-modified fullerene on tumor. Jpn J Cancer Res 88:1108-1116.
128. Taroni P, D'Andrea C, Valentini G, Cubeddu R, Hu DN, Roberts JE (2011) Fullerol in human lens and retinal pigment epithelial cells: time domain fluorescence spectroscopy and imaging. Photochem Photobiol Sci 10:904-910.
129. Tokuyama H, Yamago S, Nakamura E, Shiraki T, Sogiura Y (1993) Photoinduced biochemical activity of fullerene carboxylic acid. J Am Chem Soc 115:7918-7919.
130. 60)-poly(2-oxazoline)s nanoformulation. Biomaterials 32:3654-3665.
131. 60 in micellar solutions of different solubilizers. Colloids Surf B Biointerfaces 82:46-53.
132. Totsuka Y, Higuchi T, Imai T, Nishikawa A, Nohmi T, Kato T, Masuda S, Kinae N, Hiyoshi K, Ogo S, Kawanishi M, Yagi T, Ichinose T, Fukumori N, Watanabe M, Sugimura T, Wakabayashi K (2009) Genotoxicity of nano/microparticles in in vitro micronuclei, in vivo comet and mutation assay systems. Part Fibre Toxicol 6:23.
133. 60) nanoparticles. Nanotechnology 21:375102.
134. Tsumoto H, Kawahara S, Fujisawa Y, Suzuki T, Nakagawa H, Kohda K, Miyata N (2010) Syntheses of water-soluble [60]fullerene derivatives and their enhancing effect on neurite outgrowth in NGF-treated PC12 cells. Bioorg Med Chem Lett 20:1948- 1952.
135. 60. Toxicol Lett 93:29-37.
136. Utsunomiya S, Jensen KA, Keeler GJ, Ewing RC (2002) Uraninite and fullerene in atmospheric particulates. Environ Sci Technol 36:4943-4947.
137. Vesterdal LK, Folkmann JK, Jacobsen NR, Sheykhzade M, Wallin H, Loft S, Møller P (2009) Modest vasomotor dysfunction induced by low doses of C60 fullerenes in apolipoprotein E knockout mice with different degree of atherosclerosis. Part Fibre Toxicol 6:5.
138. 60 fullerol. Adv Funct Mater 16:120-128.
139. Wielgus AR, Zhao B, Chignell CF, Hu DN, Roberts JE (2010) Phototoxicity and cytotoxicity of fullerol in human retinal pigment epithelial cells. Toxicol Appl Pharmacol 242:79-90.
140. 60-fullerene adducts. Arch Biochem Biophys 378:216-223.
141. 60): lack of lethality after high dose exposure to human epidermal and bacterial cells. Toxicol Lett 197:128-134.
142. Xia XR, Monteiro-Riviere NA, Riviere JE (2010b) Skin penetration and kinetics of pristine fullerenes (C60) topically exposed in industrial organic solvents. Toxicol Appl Pharmacol 242:29-37.
143. Xiao L, Takada H, Maeda K, Haramoto M, Miwa N (2005) Antioxidant effects of water-soluble fullerene derivatives against ultraviolet ray or peroxylipid through their action of scavenging the reactive oxygen species in human skin keratinocytes. Biomed Pharmacother 59:351-358.
144. Xiao L, Matsubayashi K, Miwa N (2007) Inhibitory effect of the water-soluble polymer-wrapped derivative of fullerene on UVAinduced melanogenesis via downregulation of tyrosinase expression in human melanocytes and skin tissues. Arch Dermatol Res 299:245-257.
145. Xiao L, Aoshima H, Saitoh Y, Miwa N (2010) Fullerene-polyvinylpyrrolidone clathrate localizes in the cytoplasm to prevent ultraviolet-A ray-induced DNA-fragmentation and activation of the transcriptional factor NF-jB. J Cell Biochem 111:955-966.
146. Xu A, Chai Y, Nohmi T, Hei TK (2009a) Genotoxic responses to titanium dioxide nanoparticles and fullerene in gpt delta transgenic MEF cells. Part Fibre Toxicol 20(6):3.
147. 60 (OH)x. J Appl Toxicol 29:578-584.
148. 14C labeling, absorption, distribution, excretion and acute toxicity. Chem Biol 2:385-389.
149. 60 solutions by photoirradiation: an EPR study. J Am Chem Soc 120:12363-12364.
150. Yamakoshi Y, Umezawa N, Ryu A, Arakane K, Miyata N, Goda Y, Masumizu T, Nagano T (2003) Active oxygen species generated from photoexcited fullerene (C60) as potential medicines: O2- versus 1O2. J Am Chem Soc 125:12803-12809.
151. Yamawaki H, Iwai N (2006) Cytotoxicity of water-soluble fullerene in vascular endothelial cells. Am J Physiol Cell Physiol 290:C1495-C1502.
152. 60)]fullerene derivatives and its mechanism. Toxicol In Vitro 16:41-46.
153. Yang XL, Huang C, Qiao XG, Yao L, Zhao DX, Tan X (2007) Photoinduced lipid peroxidation of erythrocyte membranes by a bis-methanophosphonate fullerene. Toxicol In Vitro 21:1493- 1498.
154. 60 nanoparticles. J Magn Reson Imaging 29:1432-1437.
155. Zabirnyk O, Yezhelyev M, Seleverstov O (2007) Nanoparticles as a novel class of autophagy activators. Autophagy 3:278-281.
156. Zhang B, Cho M, Fortner JD, Lee J, Huang CH, Hughes JB, Kim JH (2009) Delineating oxidative processes of aqueous C60 preparations: role of THF peroxide. Environ Sci Technol 43:108-113.
157. Zhang M, Li J, Xing G, He R, Li W, Song Y, Guo H (2011) Variation in the
158. 60) and their cytotoxicity in human keratinocytes. Photochem Photobiol 84:1215-1223.
159. 24] fullerene phototoxicity towards HaCaT keratinocytes: type I vs type II mechanisms. Chem Res Toxicol 21:1056-1063.
160. 60] and its aggregated derivatives toward human lens epithelial cells. Chem Res Toxicol 22:660-667.
161. Zhu X, Zhu L, Lang Y, Chen Y (2008) Oxidative stress and growth inhibition in the freshwater fish Carassius auratus induced by chronic exposure to sublethal fullerene aggregates. Environ Toxicol Chem 27:1979-1985.
162. 60. Biomaterials 30:6940-6946.